|
|||||
|
|
Effects of CYP3A4 inhibitors on the pharmacokinetics of maraviroc in healthy volunteers |
|
| Authors: | Samantha Abel,Deborah Russell,Richard J. Taylor-Worth,Caroline E. Ridgway,& Gary J. Muirhead |
| Affiliation: | Pfizer Global R&D, Sandwich, UK |
| Abstract: | |
| Keywords: | CYP3A4 drug interactions maraviroc pharmacokinetics protease inhibitors |